MR Spectroscopy of the Abdomen and Pelvis

Hall C
Wednesday: 13:30 – 15:30

1892.   Is Grading of Prostate Carcinoma Possible by 2D ¹H CSI? B. Pfleiderer, M. Stanka, E. Eltze, A. Maier, A. Semjonow, K.D. Sievert, W. Böker and W. Heindel, University of Münster, Münster, Germany.
1893.   A 3D Phosphorus Chemical Shift Imaging Assessment of Metabolites in the Regenerating Human Liver following Partial Hepatectomy, K.L. Zakian, Y. Fong, S. Malhotra, L. Schwartz, W. Jarnagin and J.A. Koutcher, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
1894.   Tracking Metabolic Response to Neo-Adjuvant Chemotherapy in Prostate Cancer by Proton Magnetic Resonance Spectroscopic Imaging, K.L. Zakian, J.P. Dyke, J. Kurhanewicz, W.K. Kelly, L. Schwartz, P. Scardino, D. Vigneron, S.J. Nelson and J.A. Koutcher, Memorial Sloan-Kettering Cancer Center, New York, NY, USA and University of California at San Francisco, San Francisco, CA, USA.
1895.   Measurement of Liver TCA Cycle Flux in Awake Rats, V.P. Lebon, S. Dufour, G.W. Cline, B.M. Jucker, K.S. Cadman and G.I. Shulman, Yale University School of Medicine, New Haven, CT, USA.
1896.   In Vivo 1H MRS of Malignant Extra-Cranial Tumours at 1.5T: Observed Metabolite Signals and Changes in Response to Chemotherapy, A.J. Schwarz, D.J. Collins, N.R. Maisey, G.S. Payne, F.L. Kinnaird, R. Huddart, D. Cunningham and M.O. Leach, Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, Surrey, UK.
1897.   The Biliary Excretion of a Xenobiotic Demonstrated In Vivo at 1.5T Using ¹H-MRS, A.S.K. Dzik-Jurasz, P.S. Murphy, M.O. Leach and I.J. Rowland, Institute of Cancer Research and the Royal Marsden NHS Trust, Sutton, Surrey, UK.
1898.   ¹H-NMR and ESR Spectroscopic Assessment of Cyanobacterial Toxin-Induced Liver Damage in Rats, S.A. Sturgeon, R.A. Towner and K.E. Hore, James Cook University, Townsville, Queensland, Australia.
1899.   Spectral Characterization of Prostate Biopsies After External Beam Radiotherapy, T. Bezabeh, C. Menard, L. Leboldus, C. Littman and I.C.P. Smith, National Research Council of Canada,; Manitoba Cancer Research and Treatment Foundation, Winnipeg Clinic, and University of Manitoba, Winnipeg, Manitoba, Canada.
1900.   The Hepatobiliary 19F-MRS Catabolite Signal Detected From Patients on Protracted Venous Infusion of 5-Fluorouracil is Detected Predominantly in the Gallbladder, A.S.K. Dzik-Jurasz, D.J. Collins, M.O. Leach and I.J. Rowland, Royal Marsden Hospital, Sutton, Surrey, UK.
1901.   ²³Na MRI Study of the Intact Rat Kidneys: Effect of Diuretics on the Sodium Gradient, N. Maril, R. Margalit, M. Brezis and H. Degani, The Weizmann Institute of Science, Rehovot, Israel and Hadassah University Hospital, Jerusalem, Israel.
1902.   Pre-Treatment Phosphorus MR Spectroscopy (³¹P-MRS) Aids in Determination of Tumor Aggressiveness and Early Prediction of Treatment Response in Non-Hodgkin's Lymphoma In Vivo, F. Arias-Mendoza, M.R. Smith and T.R. Brown, Fox Chase Cancer Center, Philadelphia, PA, USA.
1903.   Proton MR Spectroscopy of Prostate Cancer: Comparison 2D-CSI Technique Using Phased-Array Coil with Using Endorectal Surface Coil, Y. Kaji, K. Sugimura, M. Matsuo, M. Matsuki, T. Imoto, Y. Kobashi, K. Maruyama and O. Takizawa, Tenri Hospital, Tenri, Japan; Kobe University, Kobe, Japan and Siemens-Asahi Medical Technologies, Tokyo, Japan.
1904.   Clinical MR-Spectroscopy of Patients During Radiotherapy Under Treatment of Erythropoietin to Correct for Anemia, M. Büchert, C. Altehoefer, K. Fischer, S. Bartelt, M. Henke and J. Hennig, University of Freiburg, Freiburg, Germany.
1905.   Evidence of Strong Coupling in Human Prostate Using Endorectal 2D JPRESS Spectroscopy In Vivo, M.A. Thomas, M. Raman, A. Marumoto, K. Yue, N. Binesh and Z. Barbaric, University of California, Los Angeles, CA, USA.
1906.   The Role of High Resolution MRI and In Vivo MRS in Assessing Response of Stage Ib Cervical Carcinoma to Neoadjuvant Chemotherapy, M.M. Mahon, A.D. Williams, G.A. Coutts, W.P. Soutter, G.A. McIndoe and N.M. deSouza, Hammersmith Hospital, London, UK.
1907.   Evaluation of Female Intrapelvic Tumors by Clinical Proton MR Spectroscopy, T. Okada, M. Harada, K. Matsuzaki, S. Hisaoka, H. Nishitani, M. Nishimura and T. Aono, Tokushima University, Tokushima, Japan.

Return to ISMRM program